2021
DOI: 10.5946/ce.2020.243
|View full text |Cite
|
Sign up to set email alerts
|

The Outcome of Endoscopic Radiofrequency Anti-Reflux Therapy (STRETTA) for Gastroesophageal Reflux Disease in Patients with Previous Gastric Surgery: A Prospective Cohort Study

Abstract: INTRODUCTION Endoscopic radiofrequency therapy for gastro-esophageal reflux disease (GERD) has been proven to be successful. 1 STRETTA is the only radiofrequency device licensed for this indication in the UK and is approved by The National Institute for Health and Care Excellence (NICE) for cases refractory to medical therapy. 2 STRETTA improves the quality of life and reduces the need for anti-reflux medication in a select group of patients, 3 namely those with uncomplicated GERD. Complicated GERD is defined … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 12 publications
0
6
0
Order By: Relevance
“…In a small cohort study including 7 patients with a history of TIF and who were followed for 23 months, the reflux symptoms significantly improved in all patients following Stretta. 27 Three patients discontinued their PPI, while 3 others were on a reduced dose. Only 1 patient did not discontinue or reduce the PPI usage, but did not require H2RB anymore.…”
Section: Stretta Systemmentioning
confidence: 99%
“…In a small cohort study including 7 patients with a history of TIF and who were followed for 23 months, the reflux symptoms significantly improved in all patients following Stretta. 27 Three patients discontinued their PPI, while 3 others were on a reduced dose. Only 1 patient did not discontinue or reduce the PPI usage, but did not require H2RB anymore.…”
Section: Stretta Systemmentioning
confidence: 99%
“…14 Stretta is the only RF device licenced by the National Institute for Health and Care Excellence for use in the UK for refractory GERD. 15 It uses a balloon-tipped four-needle catheter to deliver RF to the LES while irrigating the mucosa to prevent heat injury. 1 The safety, short-and long-term efficacy, reduction in PPI dependency, improvement in the QOL, and patient satisfaction with Stretta have been evaluated multiple times with mixed results.…”
Section: Introductionmentioning
confidence: 99%
“…5 In this study, reflux symptoms of almost all the patients (6/7) improved after Stretta. 6 Stretta was also effective for the patients who had undergone other surgeries such as fundal gastrointestinal stromal tumor resection and vagotomy with pyloroplasty. Because these surgeries do not affect the GEJ anatomy, GERD symptoms were successfully controlled with Stretta.…”
mentioning
confidence: 99%